Fate Therapeutics, Inc. (FATE)
1.27
-0.07
(-5.22%)
USD |
NASDAQ |
Nov 13, 09:56
Fate Therapeutics Free Cash Flow (Quarterly) : -27.89M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -27.89M |
| June 30, 2026 | -23.51M |
| March 31, 2026 | -31.06M |
| December 31, 2025 | -24.51M |
| September 30, 2025 | -26.58M |
| June 30, 2025 | -25.95M |
| March 31, 2025 | -35.00M |
| December 31, 2024 | -27.90M |
| September 30, 2024 | -29.91M |
| June 30, 2024 | -32.36M |
| March 31, 2024 | -33.44M |
| December 31, 2023 | -36.82M |
| September 30, 2023 | -38.84M |
| June 30, 2023 | -30.69M |
| March 31, 2023 | -32.07M |
| December 31, 2022 | -82.07M |
| September 30, 2022 | -63.72M |
| June 30, 2022 | -63.29M |
| March 31, 2022 | -74.70M |
| December 31, 2021 | -88.66M |
| September 30, 2021 | -48.11M |
| June 30, 2021 | -45.72M |
| March 31, 2021 | -31.08M |
| December 31, 2020 | -22.94M |
| September 30, 2020 | -31.69M |
| Date | Value |
|---|---|
| June 30, 2020 | 38.20M |
| March 31, 2020 | -27.74M |
| December 31, 2019 | -28.12M |
| September 30, 2019 | -21.10M |
| June 30, 2019 | -22.10M |
| March 31, 2019 | -19.24M |
| December 31, 2018 | -12.14M |
| September 30, 2018 | -4.28M |
| June 30, 2018 | -11.80M |
| March 31, 2018 | -12.74M |
| December 31, 2017 | -11.52M |
| September 30, 2017 | -10.22M |
| June 30, 2017 | -9.283M |
| March 31, 2017 | -7.61M |
| December 31, 2016 | -7.591M |
| September 30, 2016 | -7.549M |
| June 30, 2016 | -7.71M |
| March 31, 2016 | -7.43M |
| December 31, 2015 | -7.148M |
| September 30, 2015 | -7.786M |
| June 30, 2015 | 1.866M |
| March 31, 2015 | -6.827M |
| December 31, 2014 | -6.425M |
| September 30, 2014 | -5.708M |
| June 30, 2014 | -5.515M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.7296M |
| Agenus, Inc. | -20.10M |
| Amgen, Inc. | 3.654B |
| Anika Therapeutics, Inc. | 6.716M |
| BioCryst Pharmaceuticals, Inc. | 32.46M |